Bringing Science to Society

Wayne B. Weisman

Executive Chairman of the Board

Wayne B. Weisman has been a director of the company since 2008. In 2023, he was appointed the executive chairman of the board. Since 2007, Mr. Weisman has been a director of the corporate general partner of the common general partner of SCP Vitalife, which beneficially owns 33.6% of our outstanding stock as of April 1, 2016. He has also served as a managing member of SCP Vitalife Management Company, LLC, which by contract provides certain management services to the common general partner of SCP Vitalife.

Mr. Weisman has also led the activities of SCP Private Equity Partners II, L.P., a venture capital fund of which he and Mr. Churchill are principals in the life sciences area. His activities include investments in the United States and Israel. He has also led several other technology investments for SCP Private Equity Partners II, L.P. He has been a member of the investment committee of the Vitalife Life Sciences funds since their inception in 2002 and has worked closely with these funds since then.

Mr. Weisman has been a member of the board of directors of CIP Capital L.P., a small business investment company licensed by the U.S. Small Business Administration since its inception in 1991. From 1992 to 1994, Mr. Weisman was executive vice president and member of the board of directors of a public drug delivery technology company. In addition, he also operated a management and financial advisory firm focusing on the reorganization and turnaround of troubled companies and began his career practicing reorganization law at a large Philadelphia law firm.

Mr. Weisman possesses extensive experience in venture capital investing, particularly in the life sciences area. He serves on the board of ReWalk Robotics Ltd. and on a number of private company boards, including the boards of DIR Technologies, Endospan Ltd., Ivenix, LLC, and Echo360, Inc. Mr. Weisman is the chairman of the boards of trustees of Young Scholars School, Young Scholars Frederick Douglass, and Young Scholars Kenderton. He is also an advisory board member of the Philadelphia-Israel Chamber of Commerce and Mid-Atlantic Diamond Ventures, the venture forum of Temple University. Mr. Weisman holds a B.A. from the University of Pennsylvania and a J.D. from the University of Michigan Law School.

As a long-time director of our company, Mr. Weisman’s extensive knowledge of our business and history, experience as a board member of multiple publicly traded and privately held companies, and expertise in developing, financing, and providing strong executive leadership to numerous growing life science companies contributed to our board’s conclusion that he should serve as a director of our company.